NCD--Substance Induced, + d/t HIV, Prion, Parkinsons, Huntingtons, Other Flashcards

1
Q

what are the DSM criteria for substance/medication induced Major or Mild NCD

A

A–> criteria are met for a major or mild NCD

B–> neurocognitive impairments do not occur exclusively during the course of a delirium and persist beyond the usual duration of intoxication and acute withdrawal

C–> involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment

D–> temporal course of the neurocognitive deficits is consistent with the timing of substance or medication use and abstinence (i.e deficits remain stable or improve after a period of abstinence)

E–> neurocognitive disorder not attributable to another medical condition and is not better explained by another disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what types of alcohol relayed NCDs are there

A

major NCD: nonamnestic-confabulatory type

major NCD: amnestic-confabulatory type

mild NCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 4 types of substances listed in the DSM for substance/medication induced Major or Mild NCD

A

alcohol

inhalant

sedative/hypnotic/anxiolytic

other or unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a specifier for substance/medication induced Major or Mild NCD

A

persistent–> neurocognitive impairment continues to be significant after an extended period of abstinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what neurocognitive impairment is seen most predominantly in NCDs due to sedative/anxiolytic/hypnotic drugs/meds

A

greater disturbances in MEMORY than in other cognitive functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NCD due to alcohol frequently manifests with a combination of what impairments

A

impairments in EXECUTIVE FUNCTIONING and MEMORY and LEARNING domains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the features of alcohol-induced amnestic confabulatory NCD (korsakoffs)

A

prominent amnesia (severe difficulty learning new information with rapid forgetting)

tendency to confabulate

*may co occur with signs of thiamine encephalopathy (wernicke’s) with associated features such as nystagmus and ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what ocular abnormality is associated with wernicke’s encephalopathy

A

lateral gaze paralysis (ophthalmoplegia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the more common neurocognitive symptoms related to methamphetamine use? what kind of overall NCD profile is seen in methamphetamine use

A

difficulties with learning and memory

difficulties with executive function

*most common neurocognitive profile approximates that seen in vascular NCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what ocular abnormalities can be associated with methamphetamine use

A

evidence of vascular injury–> i.e focal weakness, unilateral incoordination, asymmetrical reflexes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the rate of NCD of intermediate duration in those with hx alcohol abuse

A

30-40% in the first 2 months of abstinence

–> mild NCD may persist especially in those who do not achieve stable abstinence before until after age 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

is major NCD due to alcohol abuse common

A

no–> MAJOR NCD is rare, may result from concomitant nutritional deficits as in alcohol-induced amnestic confabulatory NCD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is seen on MRI of individuals with chronic alcohol abuse

A

cortical thinning

white matter loss

enlargement of sulci and ventricles

*it is possible to observe NCDs without neuroimaging correlates however

*many of these changes reverse after period of of succesful abstinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

those with sub/med induced NCD may have deficits in what areas that are beyond that seen in many other NCDs

A

reduced cognitive capacity

difficulty concentrating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the criteria for major/mild NCD due to HIV infection

A

A–The criteria are met for major or mild neurocognitive disorder.
B–There is documented infection with human immunodeficiency virus (HIV).
C–The neurocognitive disorder is not better explained by non-HIV conditions, including secondary brain diseases such as progressive multifocal leukoencephalopathy or cryptococcal meningitis.
D–The neurocognitive disorder is not attributable to another medical condition and is not better explained by a mental disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what pattern of NCD is seen in major/mild NCD due to HIV infection

A

“subcortical pattern”

–> prominently impaired EXECUTIVE FUNCTION, slowing of processing speed, problems with more demanding attentional tasks, difficulty in learning new information

–> in major NCD due to HIV, SLOWING may be prominent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

major/mild NCD due to HIV infection show relatively preserved function in what cognitive areas

A

recall of learned information is relatively preserved

language difficulties are uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what % of those infected with HIV have at least mild neurocognitive disturbance

A

1/3 to 1/2

*may not meet full criteria for NCD

estimated 25% meet criteria for mild NCD
estimated fewer than 5% meet criteria for major NCD

19
Q

how might major/mild NCD due to HIV infection present in developing countries in which perinatal HIV transmission is common

A

may present as neurodevelopmental delay

20
Q

what are the criteria for major/mild NCD due to Prion disease

A

A–The criteria are met for major or mild neurocognitive disorder.
B–There is insidious onset, and rapid progression of impairment is common.
C–There are motor features of prion disease, such as myoclonus or ataxia, or biomarker evidence.
D–The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.

21
Q

what type of onset and progression would you expect for major/mild NCD due to Prion disease

A

insidious onset, rapid progression of impairment (i.e progression to major NCD over as little as 6 months)

22
Q

what are some motor features of prion disease

A

myoclonus

ataxia

23
Q

what is the most common spongiform encephalopathy/prion disease

A

sporadic creutzfeldt-jakob disease (CJD)

24
Q

how do those with CJD typically present

A

neurocognitive deficits

ataxia

abnormal movements–> myoclonus, chorea, dystonia

startle reflex is common

25
Q

what are the characteristic biomarker features of prion disease

A

recognized lesions on MRI with DWI or FLAIR

tau or 14-3-3 protein in CSF

characteristic TRIPHASIC waves on EEG

(family history or genetic testing for rare familial forms)

26
Q

what would be seen on EEG in prion diseases

A

characteristic triphasic waves

27
Q

what proteins would be seen in CSF in prion diseases

A

tau or 14-3-3 protein

28
Q

what is the annual incidence of sporadic CJD

A

1-2 per 1 million people

29
Q

what are prodromal symptoms of prion disease

A

fatigue, anxiety, problems with appetite or sleeping, difficulties with concentration

30
Q

what is the most sensitive diagnostic test for prion diseases currently

A

MRI with DWI–> see multifocal gray matter hyper-intensities in subcortical and cortical regions

31
Q

what is the expected onset and progression of major/mild NCD due to parkinsons disease

A

insidious onset

GRADULE progression of impairment

32
Q

list features that are frequently present in the context of major/mild NCD due to parkinsons disease

A

apathy

depressed mood

anxious mood

hallucinations

delusions

personality changes

REM sleep behaviour disorder

excessive daytime sleepiness

33
Q

what is the prevalence of parkinsons disease in people older than 85

A

3%

34
Q

what % of those with parkinsons disease will develop a major NCD sometime in the course of their illness

A

75%

35
Q

what are risk factors for development of parkinsons disease

A

exposure to herbicides and pesticides

RFs for development of NCD in parkinsons = older age at disease onset and increasing duration of disease

36
Q

what type of neuroimaging may be helpful to distinguish lewy body vs non-lewy body dementias

A

dopatmine transporter scans i.e DaT scans or structural neuroimaging scans

37
Q

how do you distinguish between the two lewy body dementias (parkinsons and dementia with lewy bodies)

A

onset and timing–> for parkinsons, motor and other symptoms must have been present for about a year before onset of cognitive symptoms

for dementia with lewy bodies, cognitive symptoms begin at the same time or shortly before motor symptoms

38
Q

what are the early cognitive changes seen in huntingtons disease

A

executive function (rather than learning and memory)

often precede the emergence of the typical motor abnormalities of huntingtons disease

39
Q

what are the typical motor abnormalities of huntingtons disease

A

bradykinesia and chorea

40
Q

what is the genetic abnormality responsible for huntingtons disease

A

CAG trinucleotide repeat expansion in the HTT gene on chromosome 4

*fully penetrant, autosomal dominant (repeat length of 36 or more is invariably associated with huntingtons disease)

41
Q

what psychiatric symptoms may be associated with huntingtons disease

A

depression

irritability

anxiety

obsessive-compulsive symptoms

apathy

psychosis–more rare

42
Q

what is the average age at diagnosis of huntingtons disease

A

40

43
Q

what is the median survival after motor symptom diagnosis of huntingtons disease

A

about 15 years

*psychiatric and cognitive symptoms of huntingtons disease can predate motor symptoms by as much as 15 years

44
Q

what neuroimaging changes are seen in those with huntingtons disease

A

volume loss in basal ganglia (particularly caudate nucleus and putamen)